P-Selectin Glycoprotein Ligand-1 (PSGL-1) is a cell surface glycoprotein that plays a key role in mediating leukocyte adhesion to endothelial cells during inflammation. PSGL-1 binds specifically to P-selectin, a receptor expressed on activated endothelial cells and platelets, facilitating the initial capture and rolling of leukocytes at sites of injury or infection. This interaction is crucial for the subsequent recruitment of immune cells to inflamed tissues. Beyond its role in immune response, PSGL-1 has been implicated in various pathophysiological processes, including cancer metastasis and chronic inflammatory diseases. Research into PSGL-1 has led to the development of therapeutic strategies targeting this interaction to modulate immune responses and treat conditions such as atherosclerosis and rheumatoid arthritis. Additionally, PSGL-1 serves as a valuable biomarker for disease activity and progression, offering potential applications in diagnostic assays and personalized medicine approaches.
